EMA shortages Shortage resolved Medicine shortages
Kevzara — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Kevzara
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): sarilumab
- Therapeutic area: Arthritis, Rheumatoid
- Pharmaceutical forms affected: Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection
- Strengths affected: 150 mg;200 mg
- Last updated: 14/09/2023
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗